New Nordic Healthbrands Overview

  • Founded
  • 1990

  • Status
  • Public

  • Employees
  • 73

  • Stock Symbol
  • NNH

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $1.98

  • (As of Thursday Closing)

New Nordic Healthbrands General Information


New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Stock Exchange
Primary Office
  • The Point, Hyllie Boulevard 34
  • PO Box 37
  • 215 32 Malmo
  • Sweden
+46 000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

New Nordic Healthbrands Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.98 $1.95 $1.88 - $12.43 $12.3M 6.2M 5.31K -$0.08

New Nordic Healthbrands Financials Summary

In Thousands,
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 30,060 60,736 43,530 54,158
Revenue 54,425 59,950 48,812 47,853
EBITDA 71 3,433 2,667 3,913
Net Income (468) 2,481 1,927 2,968
Total Assets 24,375 26,338 23,344 21,090
Total Debt 4,232 2,699 191 1,067
Public Fundamental Data provided by Morningstar, Inc. disclaimer

New Nordic Healthbrands Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore New Nordic Healthbrands‘s full profile, request access.

Request a free trial

New Nordic Healthbrands Patents

New Nordic Healthbrands Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-6794495-B1 For the cytotoxic enhancement of lymphocytes; immunotherapy; immunostimulants Inactive 19-Oct-1998 0000000000

New Nordic Healthbrands Executive Team (3)

Name Title Board Seat Contact Info
Karl Jensen Founder , Chief Executive Officer & Board Member
Ivan Ruscic Chief Financial Officer
Ditte Bihorac Chief Operating Officer
To view New Nordic Healthbrands’s complete executive team members history, request access »

New Nordic Healthbrands Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

New Nordic Healthbrands Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 03-Oct-2007 0000000000 00.000 Personal Products 0000 0000
To view New Nordic Healthbrands’s complete acquisitions history, request access »